LSE - Delayed Quote NOK

Hofseth BioCare ASA (0Q6H.L)

2.1564 -0.8536 (-28.36%)
At close: March 15 at 11:47 AM GMT
Loading Chart for 0Q6H.L
DELL
  • Previous Close 3.0100
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 3.3500
  • Volume 0
  • Avg. Volume 35,386
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 0.44
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3780
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2000 and is headquartered in Ålesund, Norway.

www.hofsethbiocare.com

69

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0Q6H.L

Performance Overview: 0Q6H.L

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0Q6H.L
0.00%
MSCI WORLD
4.78%

1-Year Return

0Q6H.L
--
MSCI WORLD
11.01%

3-Year Return

0Q6H.L
--
MSCI WORLD
11.01%

5-Year Return

0Q6H.L
--
MSCI WORLD
11.01%

Compare To: 0Q6H.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0Q6H.L

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -48.82%

  • Return on Assets (ttm)

    -16.00%

  • Return on Equity (ttm)

    -112.79%

  • Revenue (ttm)

    218.51M

  • Net Income Avi to Common (ttm)

    -106.68M

  • Diluted EPS (ttm)

    -0.3780

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23.89M

  • Total Debt/Equity (mrq)

    682.52%

  • Levered Free Cash Flow (ttm)

    -100.88M

Company Insights: 0Q6H.L